Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Patient Protection and Affordable Care Act (PPACA), Emerging Infections Program (EIP), Enhancing Epidemiology and Laboratory Capacity, Funding Opportunity Announcement (FOA) CI10-003, Initial Review, 39033 [2010-16384]
Download as PDF
cprice-sewell on DSK8KYBLC1PROD with NOTICES
Federal Register / Vol. 75, No. 129 / Wednesday, July 7, 2010 / Notices
and Co., as it relates to the proposed
indication of treatment of chronic pain.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before August 5, 2010. Oral
presentations from the public will be
scheduled between approximately 1
p.m. and 2 p.m. Those desiring to make
formal oral presentations should notify
the contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before July 28, 2010. Time allotted for
each presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by July 29, 2010.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Kalyani
Bhatt at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
VerDate Mar<15>2010
15:28 Jul 06, 2010
Jkt 220001
39033
Dated: July 1, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[FR Doc. 2010–16590 Filed 7–6–10; 8:45 am]
Notice of Submission of Proposed
Information Collection to OMB;
Emergency Comment Request; Fair
Housing Initiatives Program (FHIP)
Grant Application and Testing Training
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Patient
Protection and Affordable Care Act
(PPACA), Emerging Infections
Program (EIP), Enhancing
Epidemiology and Laboratory
Capacity, Funding Opportunity
Announcement (FOA) CI10–003, Initial
Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 8 a.m.–5 p.m., August 23,
2010 (Closed).
Place: CDC, Executive Park, Building 12,
Room 4052, Atlanta, Georgia.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Patient Protection and
Affordable Care Act (PPACA), Emerging
Infections Program (EIP), Enhancing
Epidemiology and Laboratory Capacity,
Funding Opportunity Announcement FOA
CI10–003.’’
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road, NE.,
Mailstop E60, Atlanta, GA 30333, Telephone:
(404) 498–2293.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 28, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–16384 Filed 7–6–10; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
[Docket No. FR–5376–N–58]
AGENCY: Office of the Chief Information
Officer, HUD.
ACTION: Notice of proposed information
collection.
SUMMARY: The proposed information
collection requirement described below
has been submitted to the Office of
Management and Budget (OMB) for
emergency review and approval, as
required by the Paperwork Reduction
Act. The Department is soliciting public
comments on the subject proposal.
DATES: Comments Due Date: July 14,
2010.
ADDRESSES: Interested persons are
invited to submit comments regarding
this proposal. Comments must be
received within seven (7) days from the
date of this Notice. Comments should
refer to the proposal by name/or OMB
approval number and should be sent to:
HUD Desk Officer, Office of
Management and Budget, New
Executive Office Building, Washington,
DC 20503; e-mail: OIRA_Submission
@omb.eop.gov; fax: (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Leroy McKinney, Reports Management
Officer, QDAM, Department of Housing
and Urban Development, 451 Seventh
Street, SW., Washington, DC 20410; email: Leroy.McKinneyJr@hud.gov;
telephone (202) 402–5564. This is not a
toll-free number. Copies of available
documents submitted to OMB may be
obtained from Mr. McKinney.
SUPPLEMENTARY INFORMATION: This
Notice is soliciting comments from
members of the public and affected
agencies concerning the proposed
collection of information to: (1) Evaluate
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information will have practical utility;
(2) evaluate the accuracy of the agency’s
estimate of the burden of the proposed
collection of information; (3) enhance
the quality, utility, and clarity of the
information to be collected; and (4)
minimize the burden of the collection of
information on those who are to
respond, including through the use of
appropriate automated collection
techniques or other forms of information
E:\FR\FM\07JYN1.SGM
07JYN1
Agencies
[Federal Register Volume 75, Number 129 (Wednesday, July 7, 2010)]
[Notices]
[Page 39033]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-16384]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Patient Protection and Affordable Care Act
(PPACA), Emerging Infections Program (EIP), Enhancing Epidemiology and
Laboratory Capacity, Funding Opportunity Announcement (FOA) CI10-003,
Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 8 a.m.-5 p.m., August 23, 2010 (Closed).
Place: CDC, Executive Park, Building 12, Room 4052, Atlanta,
Georgia.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Patient Protection and Affordable Care Act (PPACA),
Emerging Infections Program (EIP), Enhancing Epidemiology and
Laboratory Capacity, Funding Opportunity Announcement FOA CI10-
003.''
Contact Person for More Information: Gregory Anderson, M.S.,
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE.,
Mailstop E60, Atlanta, GA 30333, Telephone: (404) 498-2293.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: June 28, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-16384 Filed 7-6-10; 8:45 am]
BILLING CODE 4163-18-P